Success Metrics

Clinical Success Rate
88.0%

Based on 44 completed trials

Completion Rate
88%(44/50)
Active Trials
8(10%)
Results Posted
36%(16 trials)
Terminated
6(8%)

Phase Distribution

Ph not_applicable
23
29%
Ph phase_3
11
14%
Ph early_phase_1
2
3%
Ph phase_2
4
5%
Ph phase_4
27
34%
Ph phase_1
7
9%

Phase Distribution

9

Early Stage

4

Mid Stage

38

Late Stage

Phase Distribution74 total trials
Early Phase 1First-in-human
2(2.7%)
Phase 1Safety & dosage
7(9.5%)
Phase 2Efficacy & side effects
4(5.4%)
Phase 3Large-scale testing
11(14.9%)
Phase 4Post-market surveillance
27(36.5%)
N/ANon-phased studies
23(31.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

78.6%

44 of 56 finished

Non-Completion Rate

21.4%

12 ended early

Currently Active

8

trials recruiting

Total Trials

79

all time

Status Distribution
Active(11)
Completed(44)
Terminated(12)
Other(12)

Detailed Status

Completed44
unknown12
Terminated6
Withdrawn6
Recruiting5
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
79
Active
8
Success Rate
88.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.7%)
Phase 17 (9.5%)
Phase 24 (5.4%)
Phase 311 (14.9%)
Phase 427 (36.5%)
N/A23 (31.1%)

Trials by Status

not_yet_recruiting23%
enrolling_by_invitation11%
terminated68%
completed4456%
unknown1215%
withdrawn68%
active_not_recruiting34%
recruiting56%

Recent Activity

Clinical Trials (79)

Showing 20 of 79 trialsScroll for more
NCT06426836Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Recruiting
NCT03723551Phase 2

Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus

Terminated
NCT07608562Phase 4

Azithromycin for Cerclage Prophylaxis

Not Yet Recruiting
NCT03283878Phase 4

Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

Completed
NCT04875728Phase 1

The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma

Active Not Recruiting
NCT07585487

Paracetamol and Cefazolin Pharmacokinetics in Normal Weight and Overweight Children

Recruiting
NCT05137119Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Recruiting
NCT02996656Not Applicable

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

Recruiting
NCT02216227Not Applicable

Checklist to Prevent MRSA Surgical Site Infections

Completed
NCT05447559Phase 4

Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

Recruiting
NCT07478874Not Applicable

Prophylaxis Against Surgical Site Infections Using Local as Well as Systemic Antibiotic

Completed
NCT06567808Phase 4

Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial

Not Yet Recruiting
NCT03248063Not Applicable

Non-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus Bacteremia

Completed
NCT06055712Phase 4

Antibiotic Prophylaxis in Pediatric Open Fractures

Enrolling By Invitation
NCT07186894

Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia

Active Not Recruiting
NCT07111702Not Applicable

Prophylactic Antibiotics in Groin Hernioplasty

Completed
NCT02285140Not Applicable

Prevention of Infections in Cardiac Surgery

Terminated
NCT03402945Phase 4

Prevention of Infections in Cardiac Surgery (PICS) Prevena Study

Completed
NCT03862170Phase 3

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer

Terminated
NCT03094663Phase 4

Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)

Completed

Drug Details

Intervention Type
OTHER
Total Trials
79